Mechanistic insights into the vascular effects of blueberries: Evidence from recent studies

Molecular Nutrition and Food Research

Volumn 61, Issue 6, 2017, Pages

  Cutler, Brett Ronald ^a   Petersen, Chrissa ^a   Anandh Babu, Pon Velayutham ^a  

^a UNIVERSITY OF UTAH   (United States)

Author keywords

Anthocyanins; Blueberries; Dyslipidemia; Endothelium; Inflammation; Nitric oxide; Oxidative stress; Vascular effects

Indexed keywords

ANTHOCYANIN; ANTIOXIDANT; FLAVONOID;

ANIMAL; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHEMISTRY; DISEASE MODEL; DRUG EFFECTS; FRUIT; RANDOMIZED CONTROLLED TRIAL (TOPIC); SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION; VACCINIUM; VASCULAR ENDOTHELIUM;

ANIMALS; ANTHOCYANINS; ANTIOXIDANTS; BLUEBERRY PLANTS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; FLAVONOIDS; FRUIT; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84995553658     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600271     Document Type: Review

References (86)

1. Mozaffarian, D., Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation 2016, 132, 187–225.
2. Hooper, L., Kroon, P. A., Rimm, E. B., Cohn, J. S. et al., Flavonoids, flavonoid-rich foods, and cardiovascular risk: a meta-analysis of randomized controlled trials. Am. J. Clin. Nutr. 2008, 88, 38–50.
3. Mulvihill, E. E., Huff, M. W., Antiatherogenic properties of flavonoids: implications for cardiovascular health. Can. J. Cardiol. 26(Suppl A), 17A–21A.
4. Erdman, J. W., Jr., Balentine, D., Arab, L., Beecher, G. et al., Flavonoids and heart health: proceedings of the ILSI North America flavonoids workshop, May 31–June 1, 2005, Washington, DC. J. Nutr. 2007, 137, 718S–737S.
5. Beecher, G. R., Overview of dietary flavonoids: nomenclature, occurrence and intake. J. Nutr. 2003, 133, 3248S–3254S.
6. Del Rio, D., Borges, G., Crozier, A., Berry flavonoids and phenolics: bioavailability and evidence of protective effects. Br. J. Nutr. 2010, 104(Suppl 3), S67–S90.
7. Wallace, T. C., Anthocyanins in cardiovascular disease. Adv. Nutr. 2011, 2, 1–7.
8. de Pascual-Teresa, S., Moreno, D. A., Garcia-Viguera, C., Flavanols and anthocyanins in cardiovascular health: a review of current evidence. Int. J. Mol. Sci. 2010, 11, 1679–1703.
9. Babu, P. V., Liu, D., Green tea catechins and cardiovascular health: an update. Curr. Med. Chem. 2008, 15, 1840–1850.
10. Babu, P. V., Si, H., Fu, Z., Zhen, W. et al., Genistein prevents hyperglycemia-induced monocyte adhesion to human aortic endothelial cells through preservation of the cAMP signaling pathway and ameliorates vascular inflammation in obese diabetic mice. J. Nutr. 2012, 142, 724–730.
11. Babu, P. V., Si, H., Liu, D., Epigallocatechin gallate reduces vascular inflammation in db/db mice possibly through an NF-kappaB-mediated mechanism. Mol. Nutr. Food Res. 2012, 56, 1424–1432.
12. Thilakarathna, S. H., Rupasinghe, H. P., Flavonoid bioavailability and attempts for bioavailability enhancement. Nutrients 2013, 5, 3367–3387.
13. Manganaris, G. A., Goulas, V., Vicente, A. R., Terry, L. A., Berry antioxidants: small fruits providing large benefits. J. Sci. Food Agri. 2014, 94, 825–833.
14. Rodriguez-Mateos, A., Heiss, C., Borges, G., Crozier, A., Berry (poly)phenols and cardiovascular health. J. Agric. Food Chem. 2014, 62, 3842–3851.
15. Nile, S. H., Park, S. W., Edible berries: bioactive components and their effect on human health. Nutrition 2014, 30, 134–144.
16. Wu, X., Beecher, G. R., Holden, J. M., Haytowitz, D. B. et al., Concentrations of anthocyanins in common foods in the United States and estimation of normal consumption. J. Agric. Food Chem. 2006, 54, 4069–4075.
17. Basu, A., Rhone, M., Lyons, T. J., Berries: emerging impact on cardiovascular health. Nutr. Rev. 2010, 68, 168–177.
18. Michalska, A., Lysiak, G., Bioactive compounds of blueberries: post-harvest factors influencing the nutritional value of products. Int. J. Mol. Sci. 2015, 16, 18642–18663.
19. Giampieri, F., Forbes-Hernandez, T. Y., Gasparrini, M., Alvarez-Suarez, J. M. et al., Strawberry as a health promoter: an evidence based review. Food Funct. 2015, 6, 1386–1398.
20. Li, D., Wang, P., Luo, Y., Zhao, M. et al., Health benefits of anthocyanins and molecular mechanisms: update from recent decade. Critic. Rev. Food Sci. Nutr. 2015, doi: 10.1080/10408398.2015.1030064.
21. Basu, A., Lyons, T. J., Strawberries, blueberries, and cranberries in the metabolic syndrome: clinical perspectives. J. Agric. Food Chem. 2012, 60, 5687–5692.
22. Rodriguez-Mateos, A., Rendeiro, C., Bergillos-Meca, T., Tabatabaee, S. et al., Intake and time dependence of blueberry flavonoid-induced improvements in vascular function: a randomized, controlled, double-blind, crossover intervention study with mechanistic insights into biological activity. Am. J. Clin. Nutr. 2013, 98, 1179–1191.
23. Johnson, S. A., Figueroa, A., Navaei, N., Wong, A. et al., Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial. J. Acad. Nutr. Dietetics 2015, 115, 369–377.
24. Basu, A., Du, M., Leyva, M. J., Sanchez, K. et al., Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome. J. Nutr. 2010, 140, 1582–1587.
25. Lila, M. A., Burton-Freeman, B., Grace, M., Kalt, W., Unraveling anthocyanin bioavailability for human health. Ann. Rev. Food Sci. Tech. 2016, 7, 375–393.
26. Celli, G. B., Ghanem, A., Brooks, M. S., A theoretical physiologically-based pharmacokinetic approach for modelling the fate of anthocyanins in vivo. Cri. Rev. Food Sci. Nutr. 2016, doi: 10.1080/10408398.2015.1104290.
27. Kuntz, S., Rudloff, S., Asseburg, H., Borsch, C. et al., Uptake and bioavailability of anthocyanins and phenolic acids from grape/blueberry juice and smoothie in vitro and in vivo. Br. J. Nutr. 2015, 113, 1044–1055.
28. Morais, C. A., de Rosso, V. V., Estadella, D., Pisani, L. P., Anthocyanins as inflammatory modulators and the role of the gut microbiota. J. Nutr. Biochem. 2016, 33, 1–7.
29. Faria, A., Fernandes, I., Norberto, S., Mateus, N. et al., Interplay between anthocyanins and gut microbiota. J. Agric. Food Chem. 2014, 62, 6898–6902.
30. Kahle, K., Kraus, M., Scheppach, W., Ackermann, M. et al., Studies on apple and blueberry fruit constituents: do the polyphenols reach the colon after ingestion? Mol. Nutr. Food Res. 2006, 50, 418–423.
31. Marin, L., Miguelez, E. M., Villar, C. J., Lombo, F., Bioavailability of dietary polyphenols and gut microbiota metabolism: antimicrobial properties. Bio. Med. Res. Int. 2015, 2015, 905215.
32. Yang, M., Koo, S. I., Song, W. O., Chun, O. K., Food matrix affecting anthocyanin bioavailability: review. Curr. Med. Chem. 2011, 18, 291–300.
33. Ribnicky, D. M., Roopchand, D. E., Oren, A., Grace, M. et al., Effects of a high fat meal matrix and protein complexation on the bioaccessibility of blueberry anthocyanins using the TNO gastrointestinal model (TIM-1). Food Chem. 2014, 142, 349–357.
34. Correa-Betanzo, J., Padmanabhan, P., Corredig, M., Subramanian, J. et al., Complex formation of blueberry (Vaccinium angustifolium) anthocyanins during freeze-drying and its influence on their biological activity. J. Agric. Food Chem. 2015, 63, 2935–2946.
35. Prior, R. L., S, E. W., T, R. R., Khanal, R. C., Wu, X., Howard, L. R., Purified blueberry anthocyanins and blueberry juice alter development of obesity in mice fed an obesogenic high-fat diet. J. Agric. Food Chem. 2010, 58, 3970–3976.
36. de Ferrars, R. M., Czank, C., Zhang, Q., Botting, N. P. et al., The pharmacokinetics of anthocyanins and their metabolites in humans. Br. J. Pharmacol. 2014, 171, 3268–3282.
37. de Ferrars, R. M., Cassidy, A., Curtis, P., Kay, C. D., Phenolic metabolites of anthocyanins following a dietary intervention study in post-menopausal women. Mol. Nutr. Food Res. 2014, 58, 490–502.
38. Rodriguez-Mateos, A., Ishisaka, A., Mawatari, K., Vidal-Diez, A. et al., Blueberry intervention improves vascular reactivity and lowers blood pressure in high-fat-, high-cholesterol-fed rats. Br. J. Nutr. 2013, 109, 1746–1754.
39. Del Bo, C., Kristo, A. S., Kalea, A. Z., Ciappellano, S. et al., The temporal effect of a wild blueberry (Vaccinium angustifolium)-enriched diet on vasomotor tone in the Sprague-Dawley rat. Nutr. Metab. Cardiovas. Dis. 2012, 22, 127–132.
40. Blanton, C., He, Z., Gottschall-Pass, K. T., Sweeney, M. I., Probiotics blunt the anti-hypertensive effect of blueberry feeding in hypertensive rats without altering hippuric acid production. PloS One 2015, 10, e0142036.
41. Ahren, I. L., Xu, J., Onning, G., Olsson, C. et al., Antihypertensive activity of blueberries fermented by Lactobacillus plantarum DSM 15313 and effects on the gut microbiota in healthy rats. Clin. Nutr. 2015, 34, 719–726.
42. McCullough, M. L., Peterson, J. J., Patel, R., Jacques, P. F. et al., Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am. J. Clin. Nutr. 2012, 95, 454–464.
43. Mink, P. J., Scrafford, C. G., Barraj, L. M., Harnack, L. et al., Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am. J. Clin. Nutr. 2007, 85, 895–909.
44. Sesso, H. D., Gaziano, J. M., Jenkins, D. J., Buring, J. E., Strawberry intake, lipids, C-reactive protein, and the risk of cardiovascular disease in women. Am. J. Clin. Nutr. 2007, 26, 303–310.
45. Cassidy, A., Mukamal, K. J., Liu, L., Franz, M. et al., High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation 2013, 127, 188–196.
46. Toh, J. Y., Tan, V. M., Lim, P. C., Lim, S. T. et al., Flavonoids from fruit and vegetables: a focus on cardiovascular risk factors. Curr. Athero. Rep. 2013, 15, 368.
47. van Dam, R. M., Naidoo, N., Landberg, R., Dietary flavonoids and the development of type 2 diabetes and cardiovascular diseases: review of recent findings. Curr. Opin. Lipidol. 2013, 24, 25–33.
48. Yamagata, K., Tagami, M., Yamori, Y., Dietary polyphenols regulate endothelial function and prevent cardiovascular disease. Nutrition 2015, 31, 28–37.
49. McAnulty, L. S., Collier, S. R., Landram, M. J., Whittaker, D. S. et al., Six weeks daily ingestion of whole blueberry powder increases natural killer cell counts and reduces arterial stiffness in sedentary males and females. Nutr. Res. 2014, 34, 577–584.
50. Stull, A. J., Cash, K. C., Champagne, C. M., Gupta, A. K. et al., Blueberries improve endothelial function, but not blood pressure, in adults with metabolic syndrome: a randomized, double-blind, placebo-controlled clinical trial. Nutrients 2015, 7, 4107–4123.
51. Rodriguez-Mateos, A., Del Pino-Garcia, R., George, T. W., Vidal-Diez, A. et al., Impact of processing on the bioavailability and vascular effects of blueberry (poly)phenols. Mol. Nutr. Food Res. 2014, 58, 1952–1961.
52. Su, J. B., Vascular endothelial dysfunction and pharmacological treatment. Wor. J. Cardiol. 2015, 7, 719–741.
53. Chistiakov, D. A., Orekhov, A. N., Bobryshev, Y. V., Endothelial barrier and its abnormalities in cardiovascular disease. Front Physiol. 2015, 6, 365.
54. Gielis, J. F., Lin, J. Y., Wingler, K., Van Schil, P. E. et al., Pathogenetic role of eNOS uncoupling in cardiopulmonary disorders. Free Radical Biol. Med. 2011, 50, 765–776.
55. Quillon, A., Fromy, B., Debret, R., Endothelium microenvironment sensing leading to nitric oxide mediated vasodilation: a review of nervous and biomechanical signals. Nitric Oxide 2015, 45, 20–26.
56. Paneni, F., Mocharla, P., Akhmedov, A., Costantino, S. et al., Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes. Circ. Res. 2012, 111, 278–289.
57. Yang, Y. M., Huang, A., Kaley, G., Sun, D., eNOS uncoupling and endothelial dysfunction in aged vessels. Am. J. Physiol. Heart Cir. Physiol. 2009, 297, H1829–H1836.
58. Ponnuswamy, P., Schrottle, A., Ostermeier, E., Gruner, S. et al., eNOS protects from atherosclerosis despite relevant superoxide production by the enzyme in apoE mice. PloS One 2012, 7, e30193.
59. Kristo, A. S., Kalea, A. Z., Schuschke, D. A., Klimis-Zacas, D., Attenuation of alpha-adrenergic-induced vasoconstriction by dietary wild blueberries (Vaccinium angustifolium) is mediated by the NO-cGMP pathway in spontaneously hypertensive rats (SHRs). Int. J. Food Sci. Nutr. 2013, 64, 979–987.
60. Park, K. H., Park, W. J., Endothelial dysfunction: clinical implications in cardiovascular disease and therapeutic approaches. J. Kor. Med. Sci. 2015, 30, 1213–1225.
61. Elks, C. M., Reed, S. D., Mariappan, N., Shukitt-Hale, B. et al., A blueberry-enriched diet attenuates nephropathy in a rat model of hypertension via reduction in oxidative stress. PloS One 2011, 6, e24028.
62. Del Bo, C., Riso, P., Campolo, J., Moller, P. et al., A single portion of blueberry (Vaccinium corymbosum L) improves protection against DNA damage but not vascular function in healthy male volunteers. Nutr. Res. 2013, 33, 220–227.
63. Riso, P., Klimis-Zacas, D., Del Bo, C., Martini, D. et al., Effect of a wild blueberry (Vaccinium angustifolium) drink intervention on markers of oxidative stress, inflammation and endothelial function in humans with cardiovascular risk factors. Eur. J. Nutr. 2013, 52, 949–961.
64. Blacker, B. C., Snyder, S. M., Eggett, D. L., Parker, T. L., Consumption of blueberries with a high-carbohydrate, low-fat breakfast decreases postprandial serum markers of oxidation. Br. J. Nutr. 2013, 109, 1670–1677.
65. Holvoet, P., Lee, D. H., Steffes, M., Gross, M. et al., Association between circulating oxidized low-density lipoprotein and incidence of the metabolic syndrome. JAMA 2008, 299, 2287–2293.
66. Holvoet, P., Vanhaecke, J., Janssens, S., Van de Werf, F. et al., Oxidized LDL and malondialdehyde-modified LDL in patients with acute coronary syndromes and stable coronary artery disease. Circulation 1998, 98, 1487–1494.
67. Armutcu, F., Ataymen, M., Atmaca, H., Gurel, A., Oxidative stress markers, C-reactive protein and heat shock protein 70 levels in subjects with metabolic syndrome. Clin. Chem. Lab. Med. 2008, 46, 785–790.
68. Del Bo, C., Porrini, M., Fracassetti, D., Campolo, J. et al., A single serving of blueberry (V. corymbosum) modulates peripheral arterial dysfunction induced by acute cigarette smoking in young volunteers: a randomized-controlled trial. Food Funct. 2014, 5, 3107–3116.
69. Del Bo, C., Porrini, M., Campolo, J., Parolini, M. et al., A single blueberry (Vaccinium corymbosum) portion does not affect markers of antioxidant defence and oxidative stress in healthy volunteers following cigarette smoking. Mutagenesis 2016, 31, 215–224.
70. De Marchi, E., Baldassari, F., Bononi, A., Wieckowski, M. R. et al., Oxidative stress in cardiovascular diseases and obesity: role of p66Shc and protein kinase C. Oxid. Med. Cell Longev. 2013, 2013, 564961.
71. Vendrame, S., Kristo, A. S., Schuschke, D. A., Klimis-Zacas, D., Wild blueberry consumption affects aortic vascular function in the obese Zucker rat. Appl. Physiol. Nutr. Metab. 2014, 39, 255–261.
72. Coban, J., Evran, B., Ozkan, F., Cevik, A. et al., Effect of blueberry feeding on lipids and oxidative stress in the serum, liver and aorta of guinea pigs fed on a high-cholesterol diet. Biosci. Biotech. Biochem. 2013, 77, 389–391.
73. Shaughnessy, K. S., Boswall, I. A., Scanlan, A. P., Gottschall-Pass, K. T. et al., Diets containing blueberry extract lower blood pressure in spontaneously hypertensive stroke-prone rats. Nutr. Res. 2009, 29, 130–138.
74. Paneni, F., Beckman, J. A., Creager, M. A., Cosentino, F., Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part I. Eur. Heart J. 2013, 34, 2436–2443.
75. Frangogiannis, N. G., The immune system and cardiac repair. Pharmacol. Res. 2008, 58, 88–111.
76. Menzaghi, C., Bacci, S., Salvemini, L., Mendonca, C. et al., Serum resistin, cardiovascular disease and all-cause mortality in patients with type 2 diabetes. PloS One 2013, 8, e64729.
77. Whelton, A., Clinical implications of nonopioid analgesia for relief of mild-to-moderate pain in patients with or at risk for cardiovascular disease. Am. J. Cardiol. 2006, 97, 3–9.
78. Vendrame, S., Daugherty, A., Kristo, A. S., Riso, P. et al., Wild blueberry (Vaccinium angustifolium) consumption improves inflammatory status in the obese Zucker rat model of the metabolic syndrome. J. Nutr. Biochem. 2013, 24, 1508–1512.
79. Xie, C., Kang, J., Ferguson, M. E., Nagarajan, S. et al., Blueberries reduce pro-inflammatory cytokine TNF-alpha and IL-6 production in mouse macrophages by inhibiting NF-kappaB activation and the MAPK pathway. Mol. Nutr. Food Res. 2011, 55, 1587–1591.
80. Stull, A. J., Cash, K. C., Johnson, W. D., Champagne, C. M. et al., Bioactives in blueberries improve insulin sensitivity in obese, insulin-resistant men and women. J. Nutr. 2010, 140, 1764–1768.
81. Hopkins, P. N., Molecular biology of atherosclerosis. Physiol. Rev. 2013, 93, 1317–1542.
82. Kalt, W., Foote, K., Fillmore, S. A., Lyon, M. et al., Effect of blueberry feeding on plasma lipids in pigs. Br. J. Nutr. 2008, 100, 70–78.
83. Wu, T., Tang, Q., Gao, Z., Yu, Z. et al., Blueberry and mulberry juice prevent obesity development in C57BL/6 mice. PloS One 2013, 8, e77585.
84. Vendrame, S., Daugherty, A., Kristo, A. S., Klimis-Zacas, D., Wild blueberry (Vaccinium angustifolium)-enriched diet improves dyslipidaemia and modulates the expression of genes related to lipid metabolism in obese Zucker rats. Br. J. Nutr. 2014, 111, 194–200.
85. Nyberg, S., Gerring, E., Gjellan, S., Vergara, M. et al., Effects of exercise with or without blueberries in the diet on cardio-metabolic risk factors: an exploratory pilot study in healthy subjects. Upsala J. Med. Sci. 2013, 118, 247–255.
86. Czank, C., Cassidy, A., Zhang, Q., Morrison, D. J. et al., Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study. Am. J. Clin. Nutr. 2013, 97, 995–1003.